XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information (Tables)
12 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Geographic Area Information
a.
Geographic Area Information:

 

 

Israel

 

 

Canada

 

 

U.S.A.

 

 

Other

 

 

Consolidated

 

Year ended March 31, 2022 and as of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 March 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales *

 

$

47,915

 

 

$

130,066

 

 

$

376,677

 

 

$

6,689

 

 

$

561,347

 

Long-lived assets **

 

$

117,913

 

 

$

101,387

 

 

$

31,191

 

 

$

8,355

 

 

$

258,846

 

Year ended March 31, 2021 and as of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 March 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales *

 

$

46,574

 

 

$

110,167

 

 

$

383,829

 

 

$

8,400

 

 

$

548,970

 

Long-lived assets **

 

$

122,983

 

 

$

61,027

 

 

$

35,455

 

 

$

 

 

$

219,465

 

Year ended March 31, 2020 and as of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales *

 

$

42,817

 

 

$

97,997

 

 

$

495,673

 

 

$

8,282

 

 

$

644,769

 

Long-lived assets **

 

$

123,679

 

 

$

63,506

 

 

$

38,379

 

 

$

 

 

$

225,564

 

* Based on customer’s location, including sales to unaffiliated customers and Sun.

** Includes property, plant and equipment, net; goodwill and intangible assets, net.

Schedule of Sales by Therapeutic Category
c.
Sales by therapeutic category, as a percentage of total net sales for the years ended March 31, 2022, 2021, and 2020, were as follows:

 

 

 

Year ended March 31,

 

Category

 

2022

 

 

2021

 

 

2020

 

Dermatological and topical

 

 

60

%

 

 

58

%

 

 

63

%

Neuropsychiatric

 

 

13

%

 

 

16

%

 

 

17

%

Cardiovascular

 

 

6

%

 

 

7

%

 

 

6

%

Anti-inflammatory

 

 

3

%

 

 

3

%

 

 

3

%

Other

 

 

18

%

 

 

16

%

 

 

11

%

Total

 

 

100

%

 

 

100

%

 

 

100

%